Can I read DPP4/CD26 and HIV-1 COVID-19 Risk on EtoBox?

DPP4/CD26 and HIV-1 COVID-19 Risk by gopiruth4444 is a document available to read on EtoBox.

What is DPP4/CD26 and HIV-1 COVID-19 Risk about?

This study investigates the role of soluble DPP4 (sDPP4) levels and activity in HIV-1 infected individuals and its implications for COVID-19 susceptibility. It finds that HIV-1 progressors exhibit lower specific DPP4 activity and a different expression of DPP4/CD26 compared to elite controllers, which may affect their risk for severe COVID-19 outcomes. The findings suggest that DPP4 could serve as a potential biomarker and therapeutic target for managing COVID-19 in populations co-infected with HIV-1.

Author

gopiruth4444

Language

EN